News for December 2014

News Archive

New guidance provides optimism for securing life sciences patents in the US New guidance provides optimism for securing life sciences patents in the US

The US Patent and Trademark Office (USPTO) has released its 2014 Interim Guidance on Patent Subject Matter Eligibility, which will provide some optimism to those pursuing patent protection for life sciences related innovation in the US.

Team Develops ‘Cool’ New Method for Probing How Molecules Fold Team Develops ‘Cool’ New Method for Probing How Molecules Fold

Collaborating scientists from The Scripps Research Institute (TSRI) and the University of California (UC) San Diego have developed a powerful new system for studying how proteins and other biological molecules form and lose their natural folded structures.

Pricing for new drugs lacks transparency Pricing for new drugs lacks transparency

The system that allows patients rapid access to expensive new treatments lacks transparency and penalises small and low-income countries unable to negotiate lower prices with pharmaceutical manufacturers.

Volunteers Can Now Help Scripps Research Institute Scientists Seek Ebola Cure in Their (Computer's) Spare Time Volunteers Can Now Help Scripps Research Institute Scientists Seek Ebola Cure in Their (Computer's) Spare Time

IBM's SoftLayer cloud-enabled World Community Grid to provide free virtual supercomputer power to The Scripps Research Institute to speed screening of promising chemical compounds

Recently-announced timeline of Patent Box changes helps address uncertainty, says Withers & Rogers Recently-announced timeline of Patent Box changes helps address uncertainty, says Withers & Rogers

Following George Osborne’s confirmation of an overhaul of the Patent Box regime just last month, Financial Secretary to the Treasury, David Gauke, has provided much-needed clarity as to the timescales involved as part of a series of announcements made in the run up to this week’s Autumn Statement

Eli Lilly joins SBC's campus & supports neurodegenerative disease challenge Eli Lilly joins SBC's campus & supports neurodegenerative disease challenge

Company to benefit from thriving open innovation network at SBC

The Current issue of “The view from here” discusses the best of 2014. The Current issue of “The view from here” discusses the best of 2014.

The topic of this month’s newsletter from Drug Discovery Today is the best of 2014.